Preventing cytokine storm syndrome in COVID-19 using [alpha]-1 adrenergic receptor antagonists

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2020-07, Vol.130 (7), p.3345
Main Authors: Konig, Maximilian F, Staedtke, Mike Powell Verena, Bai, Ren-Yuan, Thomas, David L, Fischer, Nicole, Huq, Sakibul, Khalafallah, Adham M, Koenecke, Allison, Xiong, Ruoxuan, Mensh, Brett, Papadopoulos, Nickolas, Kinzler, Kenneth W, Vogelstein, Bert, Vogelstein, Joshua T, Athey, Susan, Zhou, Shibin, Bettegowda, Chetan
Format: Article
Language:English
Subjects:
Adult respiratory distress syndrome
China
Coronaviruses
COVID-19
Cytokines
Health aspects
Maryland
Medical schools
Mortality
Pneumonia
Prevention
Sarilumab
Severe acute respiratory syndrome
Siltuximab
T cells
United Kingdom
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 7
container_start_page 3345
container_title The Journal of clinical investigation
container_volume 130
creator Konig, Maximilian F
Staedtke, Mike Powell Verena
Bai, Ren-Yuan
Thomas, David L
Fischer, Nicole
Huq, Sakibul
Khalafallah, Adham M
Koenecke, Allison
Xiong, Ruoxuan
Mensh, Brett
Papadopoulos, Nickolas
Kinzler, Kenneth W
Vogelstein, Bert
Vogelstein, Joshua T
Athey, Susan
Zhou, Shibin
Bettegowda, Chetan
description
doi_str_mv 10.1172/JCI139642
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A630993909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A630993909</galeid><sourcerecordid>A630993909</sourcerecordid><originalsourceid>FETCH-LOGICAL-g2049-77d0645c2e3029d7984bda55907cc656ae239cfaa21491a8f9020bcd5a2bca743</originalsourceid><addsrcrecordid>eNqNz8tKAzEUBuAgCtbqwjcICIKL1CSTuWRZxttIoeKlG9FymslMozOZMknFvr1TdNFCF3IWPxy-_8BB6JTRAWMxv7xPMxbISPA91GNhmJCEB8k-6lHKGZFxkByiI-c-KGVChKKH3h9a_aWtN7bEauWbT2M1dr5pa-xWNm-bWmNjcTqeZFeESbx0a_kK1WIOb4RhyFttdVsahVut9KJrYrAeysYa590xOiigcvrkL_vo5eb6Ob0jo_Ftlg5HpORUSBLHOY1EqLgOKJd5LBMxyyEMJY2VisIINA-kKgA4E5JBUkjK6UzlIfCZglgEfXT2e7eESk-NLRrfgqqNU9NhFFApA0llp8gOVa4fgKqxujDdessPdvhucl0btbNwsVXojNffvoSlc9Ps6fH_djzZtucbdq6h8nPXVEtvGus24Q9tDpvn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preventing cytokine storm syndrome in COVID-19 using [alpha]-1 adrenergic receptor antagonists</title><source>PubMed (Medline)</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Konig, Maximilian F ; Staedtke, Mike Powell Verena ; Bai, Ren-Yuan ; Thomas, David L ; Fischer, Nicole ; Huq, Sakibul ; Khalafallah, Adham M ; Koenecke, Allison ; Xiong, Ruoxuan ; Mensh, Brett ; Papadopoulos, Nickolas ; Kinzler, Kenneth W ; Vogelstein, Bert ; Vogelstein, Joshua T ; Athey, Susan ; Zhou, Shibin ; Bettegowda, Chetan</creator><creatorcontrib>Konig, Maximilian F ; Staedtke, Mike Powell Verena ; Bai, Ren-Yuan ; Thomas, David L ; Fischer, Nicole ; Huq, Sakibul ; Khalafallah, Adham M ; Koenecke, Allison ; Xiong, Ruoxuan ; Mensh, Brett ; Papadopoulos, Nickolas ; Kinzler, Kenneth W ; Vogelstein, Bert ; Vogelstein, Joshua T ; Athey, Susan ; Zhou, Shibin ; Bettegowda, Chetan</creatorcontrib><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI139642</identifier><language>eng</language><publisher>American Society for Clinical Investigation</publisher><subject>Adult respiratory distress syndrome ; China ; Coronaviruses ; COVID-19 ; Cytokines ; Health aspects ; Maryland ; Medical schools ; Mortality ; Pneumonia ; Prevention ; Sarilumab ; Severe acute respiratory syndrome ; Siltuximab ; T cells ; United Kingdom</subject><ispartof>The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3345</ispartof><rights>COPYRIGHT 2020 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Konig, Maximilian F</creatorcontrib><creatorcontrib>Staedtke, Mike Powell Verena</creatorcontrib><creatorcontrib>Bai, Ren-Yuan</creatorcontrib><creatorcontrib>Thomas, David L</creatorcontrib><creatorcontrib>Fischer, Nicole</creatorcontrib><creatorcontrib>Huq, Sakibul</creatorcontrib><creatorcontrib>Khalafallah, Adham M</creatorcontrib><creatorcontrib>Koenecke, Allison</creatorcontrib><creatorcontrib>Xiong, Ruoxuan</creatorcontrib><creatorcontrib>Mensh, Brett</creatorcontrib><creatorcontrib>Papadopoulos, Nickolas</creatorcontrib><creatorcontrib>Kinzler, Kenneth W</creatorcontrib><creatorcontrib>Vogelstein, Bert</creatorcontrib><creatorcontrib>Vogelstein, Joshua T</creatorcontrib><creatorcontrib>Athey, Susan</creatorcontrib><creatorcontrib>Zhou, Shibin</creatorcontrib><creatorcontrib>Bettegowda, Chetan</creatorcontrib><title>Preventing cytokine storm syndrome in COVID-19 using [alpha]-1 adrenergic receptor antagonists</title><title>The Journal of clinical investigation</title><subject>Adult respiratory distress syndrome</subject><subject>China</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Cytokines</subject><subject>Health aspects</subject><subject>Maryland</subject><subject>Medical schools</subject><subject>Mortality</subject><subject>Pneumonia</subject><subject>Prevention</subject><subject>Sarilumab</subject><subject>Severe acute respiratory syndrome</subject><subject>Siltuximab</subject><subject>T cells</subject><subject>United Kingdom</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNz8tKAzEUBuAgCtbqwjcICIKL1CSTuWRZxttIoeKlG9FymslMozOZMknFvr1TdNFCF3IWPxy-_8BB6JTRAWMxv7xPMxbISPA91GNhmJCEB8k-6lHKGZFxkByiI-c-KGVChKKH3h9a_aWtN7bEauWbT2M1dr5pa-xWNm-bWmNjcTqeZFeESbx0a_kK1WIOb4RhyFttdVsahVut9KJrYrAeysYa590xOiigcvrkL_vo5eb6Ob0jo_Ftlg5HpORUSBLHOY1EqLgOKJd5LBMxyyEMJY2VisIINA-kKgA4E5JBUkjK6UzlIfCZglgEfXT2e7eESk-NLRrfgqqNU9NhFFApA0llp8gOVa4fgKqxujDdessPdvhucl0btbNwsVXojNffvoSlc9Ps6fH_djzZtucbdq6h8nPXVEtvGus24Q9tDpvn</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Konig, Maximilian F</creator><creator>Staedtke, Mike Powell Verena</creator><creator>Bai, Ren-Yuan</creator><creator>Thomas, David L</creator><creator>Fischer, Nicole</creator><creator>Huq, Sakibul</creator><creator>Khalafallah, Adham M</creator><creator>Koenecke, Allison</creator><creator>Xiong, Ruoxuan</creator><creator>Mensh, Brett</creator><creator>Papadopoulos, Nickolas</creator><creator>Kinzler, Kenneth W</creator><creator>Vogelstein, Bert</creator><creator>Vogelstein, Joshua T</creator><creator>Athey, Susan</creator><creator>Zhou, Shibin</creator><creator>Bettegowda, Chetan</creator><general>American Society for Clinical Investigation</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20200701</creationdate><title>Preventing cytokine storm syndrome in COVID-19 using [alpha]-1 adrenergic receptor antagonists</title><author>Konig, Maximilian F ; Staedtke, Mike Powell Verena ; Bai, Ren-Yuan ; Thomas, David L ; Fischer, Nicole ; Huq, Sakibul ; Khalafallah, Adham M ; Koenecke, Allison ; Xiong, Ruoxuan ; Mensh, Brett ; Papadopoulos, Nickolas ; Kinzler, Kenneth W ; Vogelstein, Bert ; Vogelstein, Joshua T ; Athey, Susan ; Zhou, Shibin ; Bettegowda, Chetan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g2049-77d0645c2e3029d7984bda55907cc656ae239cfaa21491a8f9020bcd5a2bca743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult respiratory distress syndrome</topic><topic>China</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Cytokines</topic><topic>Health aspects</topic><topic>Maryland</topic><topic>Medical schools</topic><topic>Mortality</topic><topic>Pneumonia</topic><topic>Prevention</topic><topic>Sarilumab</topic><topic>Severe acute respiratory syndrome</topic><topic>Siltuximab</topic><topic>T cells</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Konig, Maximilian F</creatorcontrib><creatorcontrib>Staedtke, Mike Powell Verena</creatorcontrib><creatorcontrib>Bai, Ren-Yuan</creatorcontrib><creatorcontrib>Thomas, David L</creatorcontrib><creatorcontrib>Fischer, Nicole</creatorcontrib><creatorcontrib>Huq, Sakibul</creatorcontrib><creatorcontrib>Khalafallah, Adham M</creatorcontrib><creatorcontrib>Koenecke, Allison</creatorcontrib><creatorcontrib>Xiong, Ruoxuan</creatorcontrib><creatorcontrib>Mensh, Brett</creatorcontrib><creatorcontrib>Papadopoulos, Nickolas</creatorcontrib><creatorcontrib>Kinzler, Kenneth W</creatorcontrib><creatorcontrib>Vogelstein, Bert</creatorcontrib><creatorcontrib>Vogelstein, Joshua T</creatorcontrib><creatorcontrib>Athey, Susan</creatorcontrib><creatorcontrib>Zhou, Shibin</creatorcontrib><creatorcontrib>Bettegowda, Chetan</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Konig, Maximilian F</au><au>Staedtke, Mike Powell Verena</au><au>Bai, Ren-Yuan</au><au>Thomas, David L</au><au>Fischer, Nicole</au><au>Huq, Sakibul</au><au>Khalafallah, Adham M</au><au>Koenecke, Allison</au><au>Xiong, Ruoxuan</au><au>Mensh, Brett</au><au>Papadopoulos, Nickolas</au><au>Kinzler, Kenneth W</au><au>Vogelstein, Bert</au><au>Vogelstein, Joshua T</au><au>Athey, Susan</au><au>Zhou, Shibin</au><au>Bettegowda, Chetan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preventing cytokine storm syndrome in COVID-19 using [alpha]-1 adrenergic receptor antagonists</atitle><jtitle>The Journal of clinical investigation</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>130</volume><issue>7</issue><spage>3345</spage><pages>3345-</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><pub>American Society for Clinical Investigation</pub><doi>10.1172/JCI139642</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3345
issn 0021-9738
1558-8238
language eng
recordid cdi_gale_infotracmisc_A630993909
source PubMed (Medline); Free E-Journal (出版社公開部分のみ）
subjects Adult respiratory distress syndrome
China
Coronaviruses
COVID-19
Cytokines
Health aspects
Maryland
Medical schools
Mortality
Pneumonia
Prevention
Sarilumab
Severe acute respiratory syndrome
Siltuximab
T cells
United Kingdom
title Preventing cytokine storm syndrome in COVID-19 using [alpha]-1 adrenergic receptor antagonists
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A25%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preventing%20cytokine%20storm%20syndrome%20in%20COVID-19%20using%20%5Balpha%5D-1%20adrenergic%20receptor%20antagonists&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Konig,%20Maximilian%20F&rft.date=2020-07-01&rft.volume=130&rft.issue=7&rft.spage=3345&rft.pages=3345-&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI139642&rft_dat=%3Cgale%3EA630993909%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g2049-77d0645c2e3029d7984bda55907cc656ae239cfaa21491a8f9020bcd5a2bca743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A630993909&rfr_iscdi=true